Zobrazeno 1 - 10
of 131
pro vyhledávání: '"Tommy A, Brown"'
Autor:
Robert C. Chick, Mark B. Faries, Diane F. Hale, Phillip M Kemp Bohan, Annelies T. Hickerson, Timothy J. Vreeland, John W. Myers III, Jessica L. Cindass, Tommy A. Brown II, John Hyngstrom, Adam C. Berger, James W. Jakub, Jeffrey J. Sussman, Montaser Shaheen, Guy T. Clifton, Hyohyun Park, Amanda J. Sloan, Thomas Wagner, George E. Peoples
Publikováno v:
Cancer Medicine, Vol 10, Iss 13, Pp 4302-4311 (2021)
Abstract Background Checkpoint inhibitors (CPI) in combination with cell‐based vaccines may produce synergistic antitumor immunity. The primary analysis of the randomized and blinded phase IIb trial in resected stage III/IV melanoma demonstrated TL
Externí odkaz:
https://doaj.org/article/a6753864134f45a6a3f365c4aa4d21de
Autor:
Tommy A. Brown, Kevin Byrd, Timothy J. Vreeland, Guy T. Clifton, Doreen O. Jackson, Diane F. Hale, Garth S. Herbert, John W. Myers, Julia M. Greene, John S. Berry, Jonathan Martin, John C. Elkas, Thomas P. Conrads, Kathleen M. Darcy, Chad A. Hamilton, George L. Maxwel, George E. Peoples
Publikováno v:
Cancer Medicine, Vol 8, Iss 10, Pp 4678-4687 (2019)
Abstract Background E39, an HLA‐A2‐restricted, immunogenic peptide derived from the folate‐binding protein (FBP), is overexpressed in multiple malignancies. We conducted a phase I/IIa trial of the E39 + GM‐CSF vaccine with booster inoculation
Externí odkaz:
https://doaj.org/article/f15fd5bad15e44cabf5f4b8e235a3c91
Autor:
Lance E. Stuke, Tommy A. Brown, Jonathan E. Schoen, Patrick Greiffenstein, Brett M. Chapman, Nicholas A Taylor, Alison Smith, Alan B. Marr, John P. Hunt
Publikováno v:
The American Surgeon. 88:840-845
Background Pelvic fractures cause significant morbidity in the trauma population. Many factors influence time to fracture fixation. No previous study has determined the optimal time window for pelvic fixation. Methods A retrospective review of trauma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5d3ae27decff28e988c0b5c30ec50179
https://doi.org/10.1177/00031348211056266
https://doi.org/10.1177/00031348211056266
Autor:
Yichi Zhang, Patrick McGrew, Chad Becnel, Chrissy Guidry, Tommy A. Brown, Eman A. Toraih, Magnus J. Chun, Mohamed Hussein, Juan Duchesne, Rebecca Schroll, Sharven Taghavi
Publikováno v:
Journal of Trauma and Acute Care Surgery. 92:528-534
Trauma scores are used to give clinicians appropriate quantitative context in making decisions. Studies show that anatomical trauma scores predicted intensive care unit admission better, while physiological trauma scores predicted mortality better. W
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9f2ccc0c33e20efda6a3ee9b336dc9b6
https://doi.org/10.1097/ta.0000000000003449
https://doi.org/10.1097/ta.0000000000003449
Autor:
Sathibalan Ponniah, Tommy A. Brown, Diane F. Hale, Constantin N. Baxevanis, N. F. Pistamaltzian, John W. Myers, Kaitlin M. Peace, Eleftheria A. Anastasopoulou, Doreen O. Jackson, Jennifer K. Litton, James L. Murray, Michael Papamichail, Nathan M. Shumway, James T. Symanowski, George E. Peoples, Alexandros Ardavanis, Elizabeth A. Mittendorf, Sonia A. Perez, Timothy J. Vreeland, Julia M. Greene, G. Travis Clifton
Publikováno v:
Breast Cancer Research and Treatment
Purpose AE37 and GP2 are HER2 derived peptide vaccines. AE37 primarily elicits a CD4+ response while GP2 elicits a CD8+ response against the HER2 antigen. These peptides were tested in a large randomized trial to assess their ability to prevent recur
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1a5ae2ea6470bd9f8fda4a1afe801b91
http://europepmc.org/articles/PMC7188712
http://europepmc.org/articles/PMC7188712
Publikováno v:
Postinjury Multiple Organ Failure ISBN: 9783030922405
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b795c16f03251884eec79870e2de5a12
https://doi.org/10.1007/978-3-030-92241-2_6
https://doi.org/10.1007/978-3-030-92241-2_6
Publikováno v:
Natural Resource Management ISBN: 9780429039706
Natural Resource Management
Natural Resource Management
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::174fabf81e8b42379c001dc8187bc404
https://doi.org/10.4324/9780429039706-4
https://doi.org/10.4324/9780429039706-4
Autor:
Timothy J. Vreeland, Chad A. Hamilton, John S. Berry, Kathleen M. Darcy, George E. Peoples, Garth S. Herbert, Kevin Byrd, Jonathan W. Martin, Tommy A. Brown, Julia M. Greene, Diane F. Hale, George L. Maxwel, Guy T. Clifton, John W. Myers, Doreen O. Jackson, John C. Elkas, Thomas P. Conrads
Publikováno v:
Cancer Medicine, Vol 8, Iss 10, Pp 4678-4687 (2019)
Cancer Medicine
Cancer Medicine
Background E39, an HLA‐A2‐restricted, immunogenic peptide derived from the folate‐binding protein (FBP), is overexpressed in multiple malignancies. We conducted a phase I/IIa trial of the E39 + GM‐CSF vaccine with booster inoculations of eith
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fa939a69a79276515650a729462bcfe0
https://doaj.org/article/f15fd5bad15e44cabf5f4b8e235a3c91
https://doaj.org/article/f15fd5bad15e44cabf5f4b8e235a3c91
Autor:
George E. Peoples, John W. Myers, Guy T. Clifton, Ravi Murthy, P. M. Kemp Bohan, EA Mittendorf, T. Vreeland, Tommy A. Brown, Diane F. Hale, JP Holmes, Jennifer K. Litton
Publikováno v:
Cancer Research. 79:P2-09
Background:HER2 low-expressing (LE) (IHC 1-2+, FISH non-amplified) breast cancer (BC) patients (pts) have not benefited from HER2-directed therapy despite HER2 antigen availability. Triple negative BC (TNBC), in particular, is immunogenic and in need
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b327d583d6161f04a34b98f545d5a4fa
https://doi.org/10.1158/1538-7445.sabcs18-p2-09-01
https://doi.org/10.1158/1538-7445.sabcs18-p2-09-01
Autor:
Timothy J. Vreeland, Hyohyun Park, Annelies T. Hickerson, Diane F. Hale, Montaser Shaheen, Jeffrey J. Sussman, Robert C. Chick, Phillip M. Kemp Bohan, Amanda JoEllen Sloan, Guy T. Clifton, Adam C. Berger, John R. Hyngstrom, Jessica L. Cindass, John W. Myers, Thomas E. Wagner, George E. Peoples, Tommy A. Brown, Mark B. Faries, James W. Jakub
Publikováno v:
Cancer Medicine
Cancer Medicine, Vol 10, Iss 13, Pp 4302-4311 (2021)
Cancer Medicine, Vol 10, Iss 13, Pp 4302-4311 (2021)
Background Checkpoint inhibitors (CPI) in combination with cell‐based vaccines may produce synergistic antitumor immunity. The primary analysis of the randomized and blinded phase IIb trial in resected stage III/IV melanoma demonstrated TLPLDC is s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6f75380951c2f4b631a85d94ac2eb3f3
https://pubmed.ncbi.nlm.nih.gov/33982452
https://pubmed.ncbi.nlm.nih.gov/33982452